Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients
Lung Cancer
Study Type
Study Phase
Study Design
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Name: Acupuncture treatment
Type: Procedure
Overall Status
This study aims for evaluating the effectiveness, safety and feasibility of additional acupuncture therapy for lung cancer patients who are under chemotherapy in an inpatient setting. The acupuncture therapy will be administered during a resting period between cycles of chemotherapy.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- At least 18 years of age

- Karnofsky Performance Status (KPS) 60% or more

- Undergoing antineoplastic chemotherapy for lung cancer

- Able to provide informed consent

Exclusion Criteria:

- Brain metastasis, stroke or major psychiatric diseases

- Active infection

- Severe heart disease

- Serious systemic diseases such as uncontrolled hypertension and diabetes mellitus

- Acupuncture therapy within the previous three months

- Communication disorder

- Unwillingness to participate in the trial

- Severe immunocompromised state (absolute neutrophils count < 1000/cubic mm)
Pusan National University Yangsan Hospital and Korean Medicine Hospital of Pusan National University
Yangsan, Gyeongsangnam-do, Korea, Republic of
Status: Recruiting
Contact: Jun-Yong Choi, MS - 82-55-360-5953 - kmd@pusan.ac.kr
Start Date
July 2011
Completion Date
December 2012
Korean Medicine Hospital of Pusan National University
Korean Medicine Hospital of Pusan National University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page